Catalent, a global leader in clinical supply services, has opened a new facility in San Diego, in response to increased demand from pharma and biopharma customers for integrated development, clinical packaging, and distribution services on the U.S. West Coast. The new facility marks the latest expansion to Catalent’s global clinical supply network, and follows the opening of a new site in Japan earlier this month.
 
The 24,000-sq.-ft. facility, located within a mile of the company’s early-phase oral drug product center of excellence, was established to support Phase 1-3 clinical studies. The site offers services including supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.
 
“Our new full-service San Diego supply facility is strategically located to work in tandem with our development center and serve customers not only on the West Coast of the U.S. and Canada, but across the world,” commented Kristen DeVito, Vice President of Operations, Clinical Supply Services, North America at Catalent. “In addition to investments we have made across our global network, the site is part of a wider strategy to provide local, integrated supply services, which offer a supply chain advantage as the world adjusts to the impact of the pandemic and its inherent logistical challenges.”
 
With a network spanning the U.S., U.K., Germany, Singapore, Japan and China, and over 50 additional global depots, Catalent’s clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.